5PDPatritumab (anti-HER3 antibody) augments anti-tumor immune response of adoptive transfer of autologous activated T cells for patient-derived xenograft models of breast cancer. (23rd October 2018) - Suzuki, E; Kotake, T; Nishimura, T; Yamaguchi, A; Pu, F; Toi, M